← Evidence map

ArticleDrug safety2020

Temelimab, an IgG4 Anti-Human Endogenous Retrovirus Monoclonal Antibody: An Early Development Safety Review.

Gabrielle Kornmann et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

15 papers cite it

2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 32794123